文献速递产科母胎医学

分娩入院时单纯收缩期重度高血压与母体不良结局

Isolated severe systolic hypertension with diastolic <110 mmHg during delivery admission and maternal outcomes: a secondary analysis of the Assessment of Perinatal Excellence cohort.
PubMed 文献 · Am J Obstet Gynecol · 2025-12-18

基于多中心Assessment of Perinatal Excellence队列115,502例患者的二次分析,纳入分娩入院期间收缩压≥140 mmHg和/或舒张压90–109 mmHg者,比较单纯收缩期重度高血压(收缩压≥160 mmHg且舒张压<110 mmHg)与轻度高血压的母体不良结局复合终点。结果显示收缩压160–179 mmHg组校正相对危险度为2.8(95%CI 2.1–3.6),≥180 mmHg组为3.8(95%CI 2.9–5.1),主要由肺水肿和肌酐升高驱动。

要点

  • 单纯收缩期重度高血压与母体不良结局复合终点呈阶梯式相关。
  • 收缩压160–179 mmHg者校正相对危险度2.8(95%CI 2.1–3.6)。
  • 收缩压≥180 mmHg者校正相对危险度3.8(95%CI 2.9–5.1)。

核心结论

  • 与轻度高血压相比,仅由收缩压诊断的重度高血压(舒张压<110 mmHg)与母体不良结局复合终点呈阶梯式相关,主要由肺水肿和肌酐升高驱动。
  • 单纯收缩期重度高血压还与重症监护病房入住、子痫及HELLP综合征相关。

研究设计与样本

  • 为多中心Assessment of Perinatal Excellence队列的二次分析,纳入2008至2011年25家医院的115,502例患者。
  • 血压取分娩入院至出院期间峰值,至少2次间隔30分钟以上的读数;纳入收缩压≥140 mmHg和/或舒张压90–109 mmHg者,排除血压正常及舒张压≥110 mmHg者。
  • 参照组为轻度高血压(收缩压140–159 mmHg和/或舒张压90–109 mmHg),研究组为单纯收缩期重度高血压(≥160 mmHg),并按峰值收缩压再分2组。
  • 主要结局为分娩入院期间不良结局复合终点,包括高血压性卒中、肺水肿、肌酐升高(≥1.5 mg/dL)、弥散性血管内凝血、心肺骤停和死亡。
  • 多变量模型校正母亲年龄、体质指数、慢性高血压、糖尿病、早产和剖宫产。

主要发现

  • 参照组轻度高血压32,277例(27.9%),收缩压160–179 mmHg者3,790例(3.3%),收缩压≥180 mmHg者2,178例(1.9%)。
  • 校正混杂因素后,峰值收缩压160–179 mmHg组复合不良结局校正相对危险度为2.8(95%CI 2.1–3.6)。
  • 峰值收缩压≥180 mmHg组校正相对危险度为3.8(95%CI 2.9–5.1),主要由肺水肿和肌酐升高驱动。
  • 按峰值收缩压更小区间分层显示与复合不良结局呈线性趋势。
  • 单纯收缩期重度高血压还与重症监护病房入住、子痫及HELLP综合征相关。

关键数值与推荐

  • 重度高血压定义:收缩压≥160 mmHg且舒张压<110 mmHg。
  • 轻度高血压参照组:收缩压140–159 mmHg和/或舒张压90–109 mmHg。
  • 肌酐升高定义为≥1.5 mg/dL。
  • 血压升高需至少2次间隔30分钟以上的读数。

临床怎么用

  • 提示临床应重视妊娠期单纯收缩压升高,即使舒张压<110 mmHg也应评估母体不良结局风险。
  • 对收缩压≥160 mmHg者需关注肺水肿和肾功能(肌酐)监测。
  • 该结果支持将收缩压作为妊娠期高血压预后评估的重要指标。

局限性

  • 缺乏治疗数据,无法评估降压治疗对结局的影响。
  • 无法确定血压测量与结局之间的时间关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Systolic hypertension has emerged as a predictor of maternal morbidity, with current guidelines recommending treatment of systolic blood pressure ≥160 mmHg regardless of diastolic values. However, evidence supporting the independent prognostic significance of elevated systolic pressure in pregnancy remains limited, as most historical data emphasized diastolic thresholds. OBJECTIVE: To evaluate whether isolated severe systolic hypertension, defined as systolic blood pressure ≥160 mmHg with diastolic pressure <110 mmHg, was associated with a composite of adverse maternal outcomes. STUDY DESIGN: This was a secondary analysis of the multicenter Assessment of Perinatal Excellence cohort, which included 115,502 patients from 2008 to 2011 at 25 hospitals participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Peak blood pressure values were obtained at any time between hospital admission for delivery and discharge, with elevated blood pressure defined by at least 2 readings taken 30 minutes or more apart. Those with a systolic blood pressure ≥140 mmHg and/or diastolic blood pressure between 90 and 109 mmHg during delivery admission were included. Normotensive patients and those with a diastolic blood pressure of ≥110 mmHg were excluded. Patients with mild hypertension (systolic blood pressure 140-159 mmHg and/or diastolic blood pressure 90-109 mmHg) comprised the reference group; the study groups included those with isolated severe systolic hypertension (≥160 mmHg), further subdivided into 2 groups based on the peak systolic blood pressure. The primary outcome was a composite of adverse outcomes documented during delivery admission, including hypertensive stroke, pulmonary edema, elevated creatinine (≥1.5 mg/dL), disseminated intravascular coagulation, cardiopulmonary arrest, and death. Multivariable models adjusted for maternal age, body mass index, chronic hypertension, diabetes, preterm birth, and cesarean delivery. RESULTS: Of the entire cohort, the reference group included 32,277 patients (27.9%) with mild hypertension, while 3790 (3.3%) had systolic blood pressure 160 to 179, and 2178 (1.9%) had systolic blood pressure ≥180 mmHg. Following adjustment for possible confounders, patients with peak systolic blood pressure of 160 to 179 had an almost 3-fold increase (adjusted relative risk, 2.8; 95% confidence interval, 2.1-3.6) in the rate of the composite adverse outcome, and those with 180 and more had an almost 4-fold increase (adjusted relative risk, 3.8; 95% confidence interval, 2.9-5.1), driven primarily by pulmonary edema and elevated creatinine. Further cohort stratification by smaller intervals of the peak systolic blood pressure showed a linear trend with the composite adverse outcome. Patients with isolated severe systolic hypertension were also more likely to be associated with intensive care unit admission, eclampsia, hemolysis, elevated liver enzymes, and low platelet syndrome. CONCLUSION: Severe hypertension diagnosed solely by systolic blood pressure (diastolic <110 mmHg) had a stepwise association with the composite adverse outcome when compared to mild hypertension, driven primarily by pulmonary edema and elevated creatinine. Interpretation is limited by the lack of treatment data and inability to determine the temporal relationship between blood pressure measurements and outcomes. These findings add to the growing evidence base recognizing the prognostic significance of systolic hypertension in pregnancy.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bart Y, Mendez-Figueroa H, Amro FH, et al. Isolated severe systolic hypertension with diastolic <110 mmHg during delivery admission and maternal outcomes: a secondary analysis of the Assessment of Perinatal Excellence cohort. Am J Obstet Gynecol. 2025. PMID: 41421751. doi:10.1016/j.ajog.2025.12.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。